In 2018, Altria announced that it entered into an agreement to acquire a 45 percent equity stake in Cronos Group Inc., a leading global cannabinoid company, headquartered in Toronto, Canada.

This investment positions Altria to participate in the emerging global cannabis sector, which we believe is poised for rapid growth over the next decade. It also creates a new growth opportunity in a category that is adjacent and complementary to our core tobacco businesses.

Cronos Group will remain a Canadian publicly-traded company.